Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00451750
NCT00451750
Completed
Not Applicable

The Efficacy of Cortisol in Combination With Behavioral Therapy in the Treatment of Phobias

University of Zurich1 site in 1 country40 target enrollmentMay 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPhobia
DrugsCortisol

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Phobia
Sponsor
University of Zurich
Enrollment
40
Locations
1
Primary Endpoint
visual analog scales for fear and acrophobia questionnaires
Status
Completed
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The aim of this prospective, double-blind, placebo-controlled, randomized study is to investigate if glucocorticoid treatment, in combination with exposure therapy, helps to reduce phobic fear in patients with phobia.

Registry
clinicaltrials.gov
Start Date
May 2007
End Date
September 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Female and male patients with a specific phobia (fear of heights) according to DSM-IV criteria.

Exclusion Criteria

  • •Severe acute or chronic somatic diseases
  • •Psychiatric disorder other than specific phobia
  • •Topic glucocorticoid therapy (for large skin parts)
  • •Inhaled glucocorticoids
  • •Psychotropic medication
  • •Pregnancy

Outcomes

Primary Outcomes

visual analog scales for fear and acrophobia questionnaires

Time Frame: 1 month

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
The Effectiveness of Oral Corticosteroids in the Treatment of Lumbar StenosisSpinal Stenosis of Lumbar Region
NCT01456377Federal University of São Paulo60
Recruiting
Phase 4
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal InsufficiencyAdrenal InsufficiencyPolymyalgia RheumaticaGiant Cell Arteritis
NCT05435781Marianne Christina Klose250
Withdrawn
Phase 4
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe SepsisSepsisAdrenal Insufficiency
NCT00368381CAMC Health System
Recruiting
Not Applicable
Corticosteroid Combining Noncorticosteroid Systemic Immunomodulatory Therapy in VKHVogt Koyanagi Harada Disease (VKH)
NCT05120687Sun Yat-sen University200
Completed
Phase 4
Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) StudyChronic Obstructive Pulmonary Disease
NCT02261727The George Institute1,670